This study measured the impact of intervention to increase awareness of the seriousness of kidney disease and the availability of effective treatments to prevent or slow kidney failure in a high-risk African- American population in four pilot cities in the U.S. Prior to launching a national education campaign, the National Kidney Disease Education Program (NKDEP) conducted pilot-site interventions to refine and test campaign strategy. Lessons learned from the pilot site initiatives were used to develop and refine the campaign for a broader national program. The campaigns focused on four cities: Jackson, MS, Cleveland, OH, Atlanta, GA, and Baltimore, MD. The targets include (1) African-Americans at risk for kidney disease, specifically those who have diabetes, hypertension, or a family history of kidney failure; and (2) primary care providers, specifically general internists, nurse practitioners, and physician assistants who treat African-American clients. This evaluation was a pre- and post-intervention comparison with a control site. The evaluation used Office of Management and Budget (OMB)-approved surveys, via telephone and fax, to collect the data. The outcome-centered evaluation assessed changes in knowledge, beliefs, awareness and practices about kidney disease among the target audiences in the intervention sites. Several key findings emerged. African-Americans identified kidney disease as a serious problem but did not know the risk factors for it, particularly familial risk, or the fact that laboratory testing was needed for detection.
Primary providers knew the major risks, and said they tested regularly. They also believed that treatment of early kidney disease was effective. However, they misinterpreted a standard laboratory test, using the serum creatinine. This has led to our efforts to provide better interpretation of that test. There were no clear differences pre- and post-comparison in the pilot or control sites. Nevertheless, the baseline data have had major effects on our activity, e.g. emphasis on risk factors including familial and better reporting of lab tests.
PIC ID: 7923; Agency Sponsor: NIH, National Institutes of Health; Federal Contact: Gladstone, Elisa, 301- 435-8116; Performer: Equals Three Communications, Bethesda, MD